1. Home
  2. RCUS vs KEN Comparison

RCUS vs KEN Comparison

Compare RCUS & KEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$28.53

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Logo Kenon Holdings Ltd.

KEN

Kenon Holdings Ltd.

HOLD

Current Price

$69.76

Market Cap

3.6B

Sector

Utilities

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCUS
KEN
Founded
2015
2014
Country
United States
Singapore
Employees
601
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Electric Utilities: Central
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.6B
IPO Year
2018
2014

Fundamental Metrics

Financial Performance
Metric
RCUS
KEN
Price
$28.53
$69.76
Analyst Decision
Buy
Analyst Count
10
0
Target Price
$31.90
N/A
AVG Volume (30 Days)
1.3M
17.7K
Earning Date
05-05-2026
05-27-2026
Dividend Yield
N/A
4.39%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$247,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$45.62
N/A
P/E Ratio
N/A
$9.21
Revenue Growth
N/A
N/A
52 Week Low
$8.84
$41.50
52 Week High
$31.74
$95.93

Technical Indicators

Market Signals
Indicator
RCUS
KEN
Relative Strength Index (RSI) 51.38 50.30
Support Level $20.20 $65.07
Resistance Level $28.72 $71.01
Average True Range (ATR) 1.33 1.19
MACD -0.16 0.83
Stochastic Oscillator 50.83 84.77

Price Performance

Historical Comparison
RCUS
KEN

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.

About KEN Kenon Holdings Ltd.

Kenon Holdings Ltd is a holding company that operates dynamic, growth-oriented businesses. The company's operating segments include: OPC Power Plants, which generates and supplies electricity and energy in Israel; and CPV Group, which generates and supplies electricity and energy in the United States. It generates maximum revenue from the OPC Power Plants segment, which generates and supplies electricity and energy in Israel. CPV Group is a limited partnership owned by OPC, which generates and supplies electricity and energy in the United States. Geographically, the company generates a majority of its revenue from Israel and the rest from the United States.

Share on Social Networks: